•
LI
LIMN
Liminatus Pharma, Inc. Class A Common Stock
polygonBIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
--
Price Chart
Market Cap
19.76M
Volume
50.48K
52W High
$33.66
52W Low
$0.61
Open
$0.73
Prev Close
$0.73
Day Range
0.69 - 0.73
About Liminatus Pharma, Inc. Class A Common Stock
Liminatus Pharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing cancer therapies and treatments. The GCC Vaccine of the company is in Phase II of clinical trials designed for immune behavior towards colorectal, pancreatic, gastric, and esophageal cancers that express Guanylyl Cyclase C.